On the following page, we will inform you about all relevant developments within the scope of the IPO of APONTIS PHARMA AG („APONTIS PHARMA“).

APONTIS PHARMA IPO

Due to applicable legal restrictions, access to this section of our website is restricted to users located in certain jurisdictions. Please confirm your location here